A carregar...

Frovatriptan: A Review of Pharmacology, Pharmacokinetics and Clinical Potential in the Treatment of Menstrual Migraine

Frovatriptan is an orally active 5-hydroxytryptamine (5-HT) receptor agonist which binds with high affinity to 5-HT(1B) and 5-HT(1D) receptors. Earlier clinical trials demonstrated that frovatriptan 2.5 mg is significantly more effective than placebo in the acute management of migraine and its assoc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Balbisi, Ebrahim A
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1936266/
https://ncbi.nlm.nih.gov/pubmed/18360605
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!